These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 1610551)
21. Development of antibiotic resistance in Pseudomonas aeruginosa during two decades of antipseudomonal treatment at the Danish CF Center. Ciofu O; Giwercman B; Pedersen SS; Høiby N APMIS; 1994 Sep; 102(9):674-80. PubMed ID: 7946270 [TBL] [Abstract][Full Text] [Related]
22. [Resistance caused by hyperproduction of chromosomal beta-lactamase in Pseudomonas aeruginosa]. Tirado M; Hermida M; Reig R; Esteva C; Vidal R; Roy C Enferm Infecc Microbiol Clin; 1989 Dec; 7(10):530-4. PubMed ID: 2518765 [TBL] [Abstract][Full Text] [Related]
23. Dissemination and diversity of metallo-beta-lactamases in Latin America: report from the SENTRY Antimicrobial Surveillance Program. Sader HS; Castanheira M; Mendes RE; Toleman M; Walsh TR; Jones RN Int J Antimicrob Agents; 2005 Jan; 25(1):57-61. PubMed ID: 15620827 [TBL] [Abstract][Full Text] [Related]
24. Purification and characterization of inducible beta-lactamases in Aeromonas spp. Iaconis JP; Sanders CC Antimicrob Agents Chemother; 1990 Jan; 34(1):44-51. PubMed ID: 2327760 [TBL] [Abstract][Full Text] [Related]
25. Characterization of Pseudomonas aeruginosa isolated from clinical and environmental samples in Minia, Egypt: prevalence, antibiogram and resistance mechanisms. Gad GF; El-Domany RA; Zaki S; Ashour HM J Antimicrob Chemother; 2007 Nov; 60(5):1010-7. PubMed ID: 17906321 [TBL] [Abstract][Full Text] [Related]
26. Role of OmpD2 and chromosomal beta-lactamase in carbapenem resistance in clinical isolates of Pseudomonas aeruginosa. Satake S; Yoneyama H; Nakae T J Antimicrob Chemother; 1991 Aug; 28(2):199-207. PubMed ID: 1778851 [TBL] [Abstract][Full Text] [Related]
27. [Antibiotic susceptibility and occurrence of ESBL in Pseudomonas aeruginosa strains isolated from different clinical specimens]. Sacha PT; Jakoniuk P; Wieczorek P; Zalewska M; Leszczyńska K Med Dosw Mikrobiol; 2004; 56(3):263-73. PubMed ID: 15773503 [TBL] [Abstract][Full Text] [Related]
28. Mechanisms of beta-lactam resistance amongst Pseudomonas aeruginosa isolated in an Italian survey. Bonfiglio G; Laksai Y; Franchino L; Amicosante G; Nicoletti G J Antimicrob Chemother; 1998 Dec; 42(6):697-702. PubMed ID: 10052891 [TBL] [Abstract][Full Text] [Related]
29. Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response. Ciofu O APMIS Suppl; 2003; (116):1-47. PubMed ID: 14692154 [TBL] [Abstract][Full Text] [Related]
30. [Prevalence of Acinetobacter baumannii and Pseudomonas aeruginosa isolates resistant to imipenem by production of metallo-beta-lactamase]. Ait El Kadi M; Aghrouch M; Seffar M; El harti J; Bouklouze A; Cherrah Y; Souly K; Zouhdi M Med Mal Infect; 2006 Jul; 36(7):386-9. PubMed ID: 16842953 [TBL] [Abstract][Full Text] [Related]
31. Effect of beta-lactamase expression on susceptibility of local isolates of Enterobacter cloacae, Serratia marcescens and Pseudomonas aeruginosa to beta-lactam antibiotics. Ramadan MA; Tawfik AF; Shibl AM Chemotherapy; 1995; 41(3):193-9. PubMed ID: 7656665 [TBL] [Abstract][Full Text] [Related]
33. Investigation of metallo-beta-lactamase producing strains of Pseudomonas aeruginosa and Acinetobacter baumannii by E-test, disk synergy and PCR. Aktaş Z; Kayacan CB Scand J Infect Dis; 2008; 40(4):320-5. PubMed ID: 17934980 [TBL] [Abstract][Full Text] [Related]
34. Incidence of strains producing plasmid determined beta-lactamases among carbenicillin resistant Pseudomonas aeruginosa. Tirado M; Roy C; Segura C; Reig R; Hermida M; Foz A J Antimicrob Chemother; 1986 Oct; 18(4):453-8. PubMed ID: 3095304 [TBL] [Abstract][Full Text] [Related]
35. [Beta-lactam resistance in aquatic Enterobacter cloacae strains using phenotypic and genotypic criteria]. Lazăr V; Cernat R; Balotescu C; Cotar A; Coipan E; Cojocaru C Bacteriol Virusol Parazitol Epidemiol; 2002; 47(3-4):185-91. PubMed ID: 15085610 [TBL] [Abstract][Full Text] [Related]
36. [Investigation of the frequency of PER-1 type beta-lactamase and antimicrobial resistance rates in nosocomial isolates of Pseudomonas aeruginosa]. Atilla A; Eroğlu C; Esen S; Sünbül M; Leblebicioğlu H Mikrobiyol Bul; 2012 Jan; 46(1):1-8. PubMed ID: 22399165 [TBL] [Abstract][Full Text] [Related]
37. Diversity of β-lactamases produced by imipenem resistant, Pseudomonas aeruginosa isolates from the bloodstream. Najar Peerayeh S; Pirhajati Mahabadi R; Pakbaten Toupkanlou S; Siadat SD Burns; 2014 Nov; 40(7):1360-4. PubMed ID: 24513132 [TBL] [Abstract][Full Text] [Related]
38. Prevalence and molecular characterisation of metallo-beta-lactamase producing strains of imipenem-resistant Pseudomonas aeruginosa in Turkey. Yilmaz NO; Agus N; Bozcal E; Uzel A Indian J Med Microbiol; 2014; 32(3):349-50. PubMed ID: 25008840 [No Abstract] [Full Text] [Related]
39. In-vitro activity of biapenem, compared with imipenem and meropenem, against Pseudomonas aeruginosa strains and mutants with known resistance mechanisms. Chen HY; Livermore DM J Antimicrob Chemother; 1994 May; 33(5):949-58. PubMed ID: 8089068 [TBL] [Abstract][Full Text] [Related]
40. Treatment of experimental pneumonia in rats caused by a PER-1 extended-spectrum beta-lactamase-producing strain of Pseudomonas aeruginosa. Mimoz O; Elhelali N; Léotard S; Jacolot A; Laurent F; Samii K; Petitjean O; Nordmann P J Antimicrob Chemother; 1999 Jul; 44(1):91-7. PubMed ID: 10459815 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]